 Aptinyx Inc. Nasdaq: APTX, a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that it will host a virtual RD; Day focused on the companys development efforts in post-traumatic stress disorder PTSD on Wednesday, August 5, 2020, from 10:00 a.m. to 11:30 a.m. ET. 